Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Syndecan-1 as an immunogene in Triple-negative breast cancer: regulation tumor-infiltrating lymphocyte in the tumor microenviroment and EMT by TGFb1/Smad pathway

Fig. 3

A The overall survival and B disease-free survival in METABRIC datasets between patients with high expression and low expression of SDC1. C SDC1 expression in patients with or without lymph node metastasis in the TCGA dataset. In the METABRIC dataset, D SDC1 expression in patients with TNBC and in other patients, E SDC1 expression in HER2-positive patients and HER2-negative patients, F SDC1 expression in patients aged ≤ 60 years old and > 60 years old

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us